A Dose Finding Study of ZW49 in Patients With HER2-Positive Cancers
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: HER2-expressing Cancers
Interventions: DRUG: ZW49
Sponsor: Zymeworks BC Inc.